Podcast description: centenarians, aging therapies and longevity biotech investing
The description says the discussion covers lessons from centenarians, emerging therapies targeting aging, epigenetic reprogramming and investment opportunities in longevity biotech. [1]
Automatic summary · not editorially reviewed
The key findings
The description says the discussion covers lessons from centenarians and emerging therapies targeting aging. [1]
The description lists the promise of epigenetic reprogramming as a topic of the conversation. [1]
The description says the discussion includes investment opportunities in longevity biotech. [1]
The source at a glance
- Study type / format
- Video description of a podcast episode
- Population / context
- A podcast discussion with longevity experts Nir Barzilai and Michael Ringel, hosted by David Berry, as described.
- Summary based on
- Creator description
- Original publication
- September 28, 2026
Centenarians and aging therapies in the description
The description states that David Berry talks with longevity experts Nir Barzilai and Michael Ringel about the science of healthier, longer lives. It lists lessons from centenarians and emerging therapies targeting aging among the topics. The description gives no details on study design, participants, measured outcomes or results for either topic.
Supporting source [1]
Epigenetic reprogramming named as a discussion topic
According to the description, the conversation also covers the promise of epigenetic reprogramming. The description does not say which cells or organisms were studied, what was measured, or whether any effect on human health or lifespan was shown. It presents the topic as part of a discussion, not as an established treatment.
Supporting source [1]
Longevity biotech investment framed as opportunity
The description says the discussion includes investment opportunities in longevity biotech. It does not name companies, products, funding figures or returns, and it gives no evidence that any investment succeeded. The description also links to listening platforms and to Averin Capital, the publisher of the episode page.
Supporting source [1]
How to interpret this
Only the video description was available; the video and transcript were not reviewed. The description names topics without study details, results or evidence, so no effect on human health or lifespan is established here.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Averin Capital · youtube.com · September 28, 2026